Department of Gastroenterology and Hepatology, Itami City Hospital, Itami, Hyogo, Japan.
Turk J Gastroenterol. 2021 Aug;32(8):622-630. doi: 10.5152/tjg.2021.20202.
Despite the progress in endoscopic hemostasis and pharmacological treatment, the mortality rate of peptic ulcer bleeding remains at 5-10%. Rebleeding after peptic ulcer bleeding is believed to be a risk factor for mortality. This study aimed to evaluate whether renal dysfunction is a predictor of rebleeding after endoscopic hemostasis in patients with peptic ulcer bleeding.
In this retrospective study, consecutive patients with peptic ulcer bleeding who underwent endoscopic hemostasis at our Hospital from January 2010 to December 2018 were enrolled. The relationship between rebleeding within 30 days after endoscopic hemostasis and the patients' admission and endoscopic characteristics were analyzed using univariate and multivariate regression models.
Out of 274 patients with peptic ulcer bleeding, 17 (6.2%) patients experienced rebleeding. In the analysis of the patients' admission characteristics, estimated glomerular filtration rate (eGFR) < 30 mL/min/1.73 m2 was an independent risk factor for rebleeding (odds ratio 4.77, 95% confidence interval 1.168-18.211, p = 0.03). Patients with eGFR < 15 mL/min/1.73 m2 with or without hemodialysis had the highest rebleeding rate at 36.8%. With respect to endoscopic characteristics, the rate of rebleeding was associated with combination therapy (p < 0.0001) and active bleeding (p = 0.03).
Renal dysfunction might be an independent risk factor for rebleeding after endoscopic hemostasis in patients with peptic ulcer bleeding.
尽管在内镜止血和药物治疗方面取得了进展,但消化性溃疡出血的死亡率仍保持在 5-10%。消化性溃疡出血后再出血被认为是死亡的危险因素。本研究旨在评估肾功能不全是否是内镜止血治疗消化性溃疡出血患者再出血的预测因素。
本回顾性研究纳入了 2010 年 1 月至 2018 年 12 月期间在我院接受内镜止血治疗的消化性溃疡出血连续患者。使用单因素和多因素回归模型分析内镜止血后 30 天内再出血与患者入院和内镜特征之间的关系。
在 274 例消化性溃疡出血患者中,17 例(6.2%)患者发生再出血。在分析患者入院特征时,估算肾小球滤过率(eGFR)<30 mL/min/1.73 m2 是再出血的独立危险因素(比值比 4.77,95%置信区间 1.168-18.211,p = 0.03)。eGFR < 15 mL/min/1.73 m2 且有或无血液透析的患者再出血率最高,达 36.8%。就内镜特征而言,再出血率与联合治疗(p<0.0001)和活动性出血(p=0.03)有关。
肾功能不全可能是内镜止血治疗消化性溃疡出血患者再出血的独立危险因素。